Evidence map›Paper›PMID 26742109›Full record

GuidelineNeuroendocrinology2016

ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.

M Falconi, B Eriksson, G Kaltsas, D K Bartsch, J Capdevila, M Caplin, B Kos-Kudla, D Kwekkeboom, G Rindi, G Klöppel and 4 more

3 registry-linked trialsAbstract readConsensus StatementPractice Guideline
In one paragraph

Guideline in Neuroendocrinology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 634 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
634citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03084770 unknown statusnot on this mapstarted 2017, after this paper: background citation

A Prospective Evaluation of the Management of Sporadic Asymptomatic Nonfunctioning Pancreatic Neuroendocrine Neoplasms ≤ 2 cm

TypeobservationalSponsorIRCCS San RaffaeleRan2017 to 2024Enrolled1,000ConditionsNon Functioning Pancreatic Endocrine TumorArmsRadiological imaging studies, Quality of Life Assessment
NCT04331912 unknown statusnot on this mapstarted 2019, after this paper: background citation

Outcomes of Patients With Advanced Neuroendocrine Cancer (NEN) Treated With Systemic Treatment: Somatostatin Analogues, Molecular Targeted Therapy, Chemotherapy and Peptide Radioisotope Therapy - a Retrospective Analysis.

TypeobservationalSponsorUniversity of Warmia and MazuryRan2019 to 2023Enrolled100ConditionsNeuroendocrine Tumors
NCT05907824 unknown statusnot on this mapstarted 2023, after this paper: background citation

Long-term Prognosis Comparison Between Parenchyma-sparing and Oncologic Resections for Non-functional Neuroendocrine Tumors of the Pancreatic Body and Tail ≤ 3cm: a Real-world Data Study

TypeobservationalSponsorFudan UniversityRan2023 to 2023Enrolled800ConditionsNon Functioning Pancreatic Endocrine TumorArmsHistopathological review, long-term prognosis and quality of life follow-up
3 · Its place in the literature

Who cites it

634 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. American Association of Clinical Endocrinology Consensus Statement on Management of Multiple Endocrine Neoplasia Type 1.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025
    Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. [Endocrine journal · 2026
    Review
  17. Article
  18. Article
  19. Review
  20. Cystic neoplasms of pancreas.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2026
    Review

574 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

M Falconi
B Eriksson
G Kaltsas
D K Bartsch
J Capdevila
M Caplin
B Kos-Kudla
D Kwekkeboom
G Rindi
G Klöppel
N Reed
R Kianmanesh
R T Jensen
Vienna Consensus Conference participants

Funding

Diagnosis, Natural History, Management,tumor biology of Gastrinomas/PETs/Neuroendocrine tumorsZIADK053200 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI JENSEN, ROBERT · 2009 to 2025
$4.3M
MANAGEMENT OF ISLET CELL TUMORSZ01DK053200 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI JENSEN, ROBERT · 1990 to 2008
$667k
Intramural NIH HHS Z01 DK053200Intramural NIH HHS Z99 DK999999
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

EuropeHumansNeuroendocrine TumorsPancreatic Neoplasms

Identifiers

PMID26742109
PMCPMC4849884

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.